💪

Pharmaceutical Bioavailability (AUC

Health Free Instant Private
Health

### Clinical Pharmacology & Pharmacokinetics: Absolute Bioavailability (F) In drug development and regulatory bioequivalence, Absolute Bioavailability (\(F\)) measures the exact.

Reviewed by Dr. Shahzad · DHMS, RMP
Last updated:
Editorial Guidelines

⚙ Input Values

📊 Results

Absolute Bioavailability & PK Summary
Bioavailability (F): 60.7% ➔ Clearance: 1.43 L/hr (23.8 mL/min) | Half-Life: 6.03 hrs (k_e: 0.115/hr) | V_d: 12.4 L (0.18 L/kg) | First-Pass Loss: 39.3%
Absolute Oral Bioavailability (F %)
60.71% Absolute Oral Bioavailability (F)
Total Systemic Clearance (CL [L / hr & mL / min])
1.43 L / hr (23.8 mL / min)
Volume of Distribution (V_d in L & L / kg)
12.4 Liters (0.18 L / kg)
Terminal Elimination Half-Life (t_1/2 [Hours])
6.03 Hours (t_1/2)
Estimated Gut / First-Pass Extraction Ratio (E_H %)
39.3% Gut Wall & Hepatic Extraction Loss
Dose-Normalized AUC Exposure Ratio (Oral / IV)
0.607 (Dose-Normalized AUC_po / AUC_iv)
✦ FDA / EMA Non-Compartmental Pharmacokinetics Diagnostic
Non-Compartmental Pharmacokinetics (NCA) Model (100mg Oral [AUC: 42.5 mg·hr/L] vs 50mg IV [AUC: 35 mg·hr/L] | 70kg Patient): [1. Absolute Bioavailability]: The drug exhibits an **Absolute Oral Bioavailability of F = 60.71%** (Moderate bioavailability, partial first-pass hepatic metabolism). [2. Elimination & Distribution]: Cleared from systemic circulation at **1.43 L/hr (23.8 mL/min [0.020 L/hr/kg])** with an apparent **Volume of Distribution (V_d) of 12.4 Liters (0.18 L/kg)**. [3. Half-Life & Dosing Interval]: Exhibits a terminal elimination half-life of **t_1/2 = 6.03 hours** (requiring ~30.1 hours [5 half-lives] for complete systemic drug washout).
Embed on Your Website

Copy and paste this code into your website.

<iframe src="https://calcusolve.com/calculator/pharmaceutical-bioavailability-auc-pharmacokinetics-engine?embed=true" width="100%" height="600" frameborder="0" loading="lazy" title="Pharmaceutical Bioavailability (AUC"></iframe>

📐 Formula

Non-Compartmental Pharmacokinetics (NCA) equations:
Absolute Bioavailability (F) = [ AUC_oral × Dose_IVAUC_IV × Dose_oral] × 100%
Total Systemic Clearance (CL) = Dose_IVAUC_IV
Terminal Elimination Half-Life (t_1/2) = ( (2) ÷ k_e) = (0.69315 ÷ k_e)
Apparent Volume of Distribution (V_d) = (CL ÷ k_e)
First-Pass Extraction Ratio (E_H) = 1 - (F ÷ 100%)

💡 Practical Example

✅

For example, evaluating an oral drug formulation administering \(100.0\text{ mg oral}\)) compared to a \(50.0\text{ mg IV reference dose}\)) with elimination rate constant \ in a \(70.0\text{ kg patient}\): Absolute Bioavailability is \. Systemic clearance is \}\), terminal half-life is \(6.03\text{ hours}\), and volume of distribution is \}\).

📖 About Pharmaceutical Bioavailability (AUC

Clinical Pharmacology & Pharmacokinetics: Absolute Bioavailability (F)

In drug development and regulatory bioequivalence, Absolute Bioavailability (F) measures the exact fraction of an active pharmaceutical ingredient (API) that reaches systemic blood circulation intact:

  • The Gold Standard IV Reference: Intravenous injection delivers 100% bioavailability by definition). Oral bioavailability compares the area under the plasma concentration-time curve (AUC) adjusted for administered doses: .
  • Mechanisms Limiting Bioavailability:
  • Incomplete Dissolution / Permeability:.
  • Efflux Transporters: P-glycoprotein (P-gp) pumping drug molecules back into the intestinal lumen.
  • First-Pass Hepatic Metabolism: Cytochrome P450 (CYP3A4) liver enzyme degradation before reaching the vena cava.
  • Volume of Distribution (V_d): A low V_d indicates retention within vascular plasma; a high V_d indicates extensive lipophilic tissue binding (e.g. brain, adipose tissue).

How to Use This Calculator

Enter your Oral Formulation Administered Dose (Dose_oral [mg]) (e.g. 100 (100 mg oral tablet / capsule)), Oral Plasma AUC_0-inf (mg·hr / L) (e.g. 42.5 (Oral Area Under Curve)), Intravenous (IV) Reference Dose (Dose_IV [mg]) (e.g. 50 (50 mg 100% bioavailable IV bolus)), IV Reference Plasma AUC_0-inf (mg·hr / L) (e.g. 35.0 (IV reference Area Under Curve)), Terminal Elimination Rate Constant (k_e [1 / hour]) (e.g. 0.115 (Terminal slope of log-linear elimination)), and Patient Body Weight (kg) (e.g. 70). Results update instantly — no submit button needed. Use metric or imperial units as labeled. For the most accurate result, measure height and weight in the morning without shoes.

The Formula

Non-Compartmental Pharmacokinetics (NCA) equations:

Absolute Bioavailability (F) = [AUC_oral × Dose_IVAUC_IV × Dose_oral] × 100\%

Total Systemic Clearance (CL) = Dose_IVAUC_IV

Terminal Elimination Half-Life (t_1/2) = ((2)) / (k_e) = (0.69315) / (k_e)

Apparent Volume of Distribution (V_d) = (CL) / (k_e)

First-Pass Extraction Ratio (E_H) = 1 - (F) / (100\%)

Worked Example

For example, evaluating an oral drug formulation administering 100.0 mg oral) compared to a 50.0 mg IV reference dose) with elimination rate constant \ in a 70.0 kg patient: Absolute Bioavailability is \. Systemic clearance is \, terminal half-life is 6.03 hours, and volume of distribution is \.

Understanding Your Result

Health calculations based on standard clinical formulas give a population-reference estimate — individual variation exists. Compare your result to the reference ranges provided using validated sources (WHO, CDC, NIH, or specialty clinical guidelines). A single measurement is a starting point; meaningful health trends emerge from tracking the same metric over time under consistent conditions. For values outside reference ranges, consult a qualified healthcare provider before making changes to diet, exercise, or medication.

💡 Expert Health Guidance & Clinical Context

  • This calculator uses clinically validated formulas and population reference data published by the WHO and NIH. Results are screening estimates, not medical diagnoses.
  • Consult a licensed healthcare provider before making any changes to diet, medication, or exercise based on these results — individual variation is significant.
  • Genetics, chronic conditions, and concurrent medications can dramatically affect what a "normal" result means for a specific individual.
  • Track your results over time: a single data point is less meaningful than a trend measured consistently across multiple weeks or months.
  • The CDC recommends adults receive routine health screenings at least annually. Use these calculations to prepare informed questions for your physician.
  • Body composition, lifestyle factors, and stress levels all interact with the metrics shown here. No single number captures your full health picture.
  • For pediatric or geriatric populations, reference ranges may differ significantly from the adult standards used in general calculators.
  • Always cross-reference results with laboratory tests, clinical examinations, and professional medical evaluation before acting on any finding.

Results are for informational and educational purposes only. Always verify critical decisions with a qualified professional.

❓ Frequently Asked Questions

What is the formula for absolute oral bioavailability (F)?

F = [ ÷] × 100%.

What is the difference between absolute and relative bioavailability?

Absolute bioavailability compares an oral formulation against a 100% bioavailable intravenous (IV) dose, while relative bioavailability compares a generic drug formulation against a branded innovator oral formulation.

How do you calculate drug clearance (CL)?

Total Systemic Clearance (CL) = Dose_IV ÷ AUC_IV.

What does a high Volume of Distribution (Vd) mean?

A Volume of Distribution greater than total body water indicates that the drug is highly lipophilic and penetrates deeply into peripheral body tissues rather than remaining in the bloodstream.

How many half-lives does it take to eliminate a drug from the body?

It takes approximately 5 elimination half-lives to eliminate 97% of a drug dose from the body.

Try Other Calculators